Coronary artery disease surveillance among childhood, adolescent and young adult cancer survivors: A systematic review and recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group.

van Dalen, Elvira C; Mulder, Renée L; Suh, Eugene; Ehrhardt, Matthew J; Aune, Gregory J; Bardi, Edit; Benson, Bradley J; Bergler-Klein, Jutta; Chen, Ming H; Frey, Eva; Hennewig, Ulrike; Lockwood, Liane; Martinsson, Ulla; Muraca, Monica; van der Pal, Helena; Plummer, Chris; Scheinemann, Katrin; Schindera, Christina; Tonorezos, Emily S; Wallace, W Hamish; ... (2021). Coronary artery disease surveillance among childhood, adolescent and young adult cancer survivors: A systematic review and recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group. European journal of cancer, 156, pp. 127-137. Elsevier 10.1016/j.ejca.2021.06.021

	Text VanDalen_EurJCancer_2021.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (602kB) | Request a copy
Preview	Text VanDalen_EurJCancer_2021_AAM.pdf - Accepted Version Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND). Download (488kB) | Preview
Preview	Text VanDalen_EurJCancer_2021_supplmat.pdf - Supplemental Material Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND). Download (1MB) | Preview

BACKGROUND

Coronary artery disease (CAD) is a concerning late outcome for cancer survivors. However, uniform surveillance guidelines are lacking.

AIM

To harmonise international recommendations for CAD surveillance for survivors of childhood, adolescent and young adult (CAYA) cancers.

METHODS

A systematic literature review was performed and evidence graded using the Grading of Recommendations, Assessment, Development and Evaluation criteria. Eligibility included English language studies, a minimum of 20 off-therapy cancer survivors assessed for CAD, and 75% diagnosed prior to age 35 years. All study designs were included, and a multidisciplinary guideline panel formulated and graded recommendations.

RESULTS

32 of 522 identified articles met eligibility criteria. The prevalence of CAD ranged from 0 to 72% and was significantly increased compared to control populations. The risk of CAD was increased among survivors who received radiotherapy exposing the heart, especially at doses ≥15 Gy (moderate-quality evidence). The guideline panel agreed that healthcare providers and CAYA cancer survivors treated with radiotherapy exposing the heart should be counselled about the increased risk for premature CAD. While the evidence is insufficient to support primary screening, monitoring and early management of modifiable cardiovascular risk factors are recommended. Initiation and frequency of surveillance should be based on the intensity of treatment exposures, family history, and presence of co-morbidities but at least by age 40 years and at a minimum of every 5 years. All were strong recommendations.

CONCLUSION

These systematically assessed and harmonised recommendations for CAD surveillance will inform care and guide research concerning this critical outcome for CAYA cancer survivors.

Interest & Impact

Downloads

7 since deposited on 07 Sep 2021
6 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item